PBM Latest Press Releases

-- May 15, 2026 --

Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing Globe Newswire 9:15 AM

-- April 23, 2026 --

Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder Globe Newswire 7:00 AM

-- April 20, 2026 --

Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source Globe Newswire 7:42 AM

-- April 17, 2026 --

Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine Globe Newswire 9:15 AM

-- April 8, 2026 --

Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5-Supported Clinical Activities Globe Newswire 9:15 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software